Global Diabetes Drugs Market Research Report 2016

October 2016 | 102 pages | ID: 27CF4DBB482EN
QYResearch

Abstracts

Notes:

Production, means the output of Diabetes Drugs

Revenue, means the sales value of Diabetes Drugs

This report studies Diabetes Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering

• Lantus
• NovoLog
• Humalog
• Levemir
• Actos

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Diabetes Drugs in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Human insulins and analogues
• Alpha-glucosidase inhibitors
• Biguanides
• DPP-4 inhibitors
• Meglitinides
• Sulphonylureas
• Thiazolidinediones

Split by application, this report focuses on consumption, market share and growth rate of Diabetes Drugs in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Diabetes Drugs Market Research Report 2016

1 DIABETES DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Diabetes Drugs
1.2 Diabetes Drugs Segment by Type
  1.2.1 Global Production Market Share of Diabetes Drugs by Type in 2015
  1.2.2 Human insulins and analogues
  1.2.3 Alpha-glucosidase inhibitors
  1.2.4 Biguanides
  1.2.5 DPP-4 inhibitors
  1.2.6 Meglitinides
  1.2.7 Sulphonylureas
  1.2.8 Thiazolidinediones
1.3 Diabetes Drugs Segment by Application
  1.3.1 Diabetes Drugs Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Diabetes Drugs Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Diabetes Drugs (2011-2021)

2 GLOBAL DIABETES DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Diabetes Drugs Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 Global Diabetes Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Diabetes Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Diabetes Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Diabetes Drugs Market Competitive Situation and Trends
  2.5.1 Diabetes Drugs Market Concentration Rate
  2.5.2 Diabetes Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL DIABETES DRUGS CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Diabetes Drugs Capacity and Market Share by Region (2011-2016)
3.2 Global Diabetes Drugs Production and Market Share by Region (2011-2016)
3.3 Global Diabetes Drugs Revenue (Value) and Market Share by Region (2011-2016)
3.4 Global Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.5 North America Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.6 Europe Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.7 China Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Japan Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.9 Southeast Asia Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.10 India Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL DIABETES DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Diabetes Drugs Consumption by Regions (2011-2016)
4.2 North America Diabetes Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Diabetes Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Diabetes Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Diabetes Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Diabetes Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Diabetes Drugs Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL DIABETES DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Diabetes Drugs Production and Market Share by Type (2011-2016)
5.2 Global Diabetes Drugs Revenue and Market Share by Type (2011-2016)
5.3 Global Diabetes Drugs Price by Type (2011-2016)
5.4 Global Diabetes Drugs Production Growth by Type (2011-2016)

6 GLOBAL DIABETES DRUGS MARKET ANALYSIS BY APPLICATION

6.1 Global Diabetes Drugs Consumption and Market Share by Application (2011-2016)
6.2 Global Diabetes Drugs Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL DIABETES DRUGS MANUFACTURERS PROFILES/ANALYSIS

7.1 Lantus
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Diabetes Drugs Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Lantus Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 NovoLog
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Diabetes Drugs Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 NovoLog Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Humalog
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Diabetes Drugs Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Humalog Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Levemir
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Diabetes Drugs Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Levemir Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Actos
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Diabetes Drugs Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Actos Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview

8 DIABETES DRUGS MANUFACTURING COST ANALYSIS

8.1 Diabetes Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Diabetes Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Diabetes Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Diabetes Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL DIABETES DRUGS MARKET FORECAST (2016-2021)

12.1 Global Diabetes Drugs Capacity, Production, Revenue Forecast (2016-2021)
12.2 Global Diabetes Drugs Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Diabetes Drugs Production Forecast by Type (2016-2021)
12.4 Global Diabetes Drugs Consumption Forecast by Application (2016-2021)
12.5 Diabetes Drugs Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Diabetes Drugs
Figure Global Production Market Share of Diabetes Drugs by Type in 2015
Figure Product Picture of Human insulins and analogues
Table Major Manufacturers of Human insulins and analogues
Figure Product Picture of Alpha-glucosidase inhibitors
Table Major Manufacturers of Alpha-glucosidase inhibitors
Figure Product Picture of Biguanides
Table Major Manufacturers of Biguanides
Figure Product Picture of DPP-4 inhibitors
Table Major Manufacturers of DPP-4 inhibitors
Figure Product Picture of Meglitinides
Table Major Manufacturers of Meglitinides
Figure Product Picture of Sulphonylureas
Table Major Manufacturers of Sulphonylureas
Figure Product Picture of Thiazolidinediones
Table Major Manufacturers of Thiazolidinediones
Table Diabetes Drugs Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Diabetes Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Diabetes Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Diabetes Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Diabetes Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Diabetes Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Diabetes Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Diabetes Drugs Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Diabetes Drugs Capacity of Key Manufacturers (2015 and 2016)
Table Global Diabetes Drugs Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Diabetes Drugs Capacity of Key Manufacturers in 2015
Figure Global Diabetes Drugs Capacity of Key Manufacturers in 2016
Table Global Diabetes Drugs Production of Key Manufacturers (2015 and 2016)
Table Global Diabetes Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Diabetes Drugs Production Share by Manufacturers
Figure 2016 Diabetes Drugs Production Share by Manufacturers
Table Global Diabetes Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Diabetes Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Diabetes Drugs Revenue Share by Manufacturers
Table 2016 Global Diabetes Drugs Revenue Share by Manufacturers
Table Global Market Diabetes Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Diabetes Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Diabetes Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Diabetes Drugs Product Type
Figure Diabetes Drugs Market Share of Top 3 Manufacturers
Figure Diabetes Drugs Market Share of Top 5 Manufacturers
Table Global Diabetes Drugs Capacity by Regions (2011-2016)
Figure Global Diabetes Drugs Capacity Market Share by Regions (2011-2016)
Figure Global Diabetes Drugs Capacity Market Share by Regions (2011-2016)
Figure 2015 Global Diabetes Drugs Capacity Market Share by Regions
Table Global Diabetes Drugs Production by Regions (2011-2016)
Figure Global Diabetes Drugs Production and Market Share by Regions (2011-2016)
Figure Global Diabetes Drugs Production Market Share by Regions (2011-2016)
Figure 2015 Global Diabetes Drugs Production Market Share by Regions
Table Global Diabetes Drugs Revenue by Regions (2011-2016)
Table Global Diabetes Drugs Revenue Market Share by Regions (2011-2016)
Table 2015 Global Diabetes Drugs Revenue Market Share by Regions
Table Global Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table China Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table India Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Diabetes Drugs Consumption Market by Regions (2011-2016)
Table Global Diabetes Drugs Consumption Market Share by Regions (2011-2016)
Figure Global Diabetes Drugs Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Diabetes Drugs Consumption Market Share by Regions
Table North America Diabetes Drugs Production, Consumption, Import & Export (2011-2016)
Table Europe Diabetes Drugs Production, Consumption, Import & Export (2011-2016)
Table China Diabetes Drugs Production, Consumption, Import & Export (2011-2016)
Table Japan Diabetes Drugs Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Diabetes Drugs Production, Consumption, Import & Export (2011-2016)
Table India Diabetes Drugs Production, Consumption, Import & Export (2011-2016)
Table Global Diabetes Drugs Production by Type (2011-2016)
Table Global Diabetes Drugs Production Share by Type (2011-2016)
Figure Production Market Share of Diabetes Drugs by Type (2011-2016)
Figure 2015 Production Market Share of Diabetes Drugs by Type
Table Global Diabetes Drugs Revenue by Type (2011-2016)
Table Global Diabetes Drugs Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Diabetes Drugs by Type (2011-2016)
Figure 2015 Revenue Market Share of Diabetes Drugs by Type
Table Global Diabetes Drugs Price by Type (2011-2016)
Figure Global Diabetes Drugs Production Growth by Type (2011-2016)
Table Global Diabetes Drugs Consumption by Application (2011-2016)
Table Global Diabetes Drugs Consumption Market Share by Application (2011-2016)
Figure Global Diabetes Drugs Consumption Market Share by Application in 2015
Table Global Diabetes Drugs Consumption Growth Rate by Application (2011-2016)
Figure Global Diabetes Drugs Consumption Growth Rate by Application (2011-2016)
Table Lantus Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lantus Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Lantus Diabetes Drugs Market Share (2011-2016)
Table NovoLog Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table NovoLog Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure NovoLog Diabetes Drugs Market Share (2011-2016)
Table Humalog Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Humalog Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Humalog Diabetes Drugs Market Share (2011-2016)
Table Levemir Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Levemir Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Levemir Diabetes Drugs Market Share (2011-2016)
Table Actos Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Actos Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Actos Diabetes Drugs Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Diabetes Drugs
Figure Manufacturing Process Analysis of Diabetes Drugs
Figure Diabetes Drugs Industrial Chain Analysis
Table Raw Materials Sources of Diabetes Drugs Major Manufacturers in 2015
Table Major Buyers of Diabetes Drugs
Table Distributors/Traders List
Figure Global Diabetes Drugs Capacity, Production and Growth Rate Forecast (2016-2021)
Figure Global Diabetes Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Diabetes Drugs Production Forecast by Regions (2016-2021)
Table Global Diabetes Drugs Consumption Forecast by Regions (2016-2021)
Table Global Diabetes Drugs Production Forecast by Type (2016-2021)
Table Global Diabetes Drugs Consumption Forecast by Application (2016-2021)